China Resources Medical Holdings CoCMHDF 88 Return-on-Tangible-Equity is 10.91% as of Dec. 2025, which is 26% below its 10-year median of 14.75. GuruFocus rates CMHDF with a GF Score™ of 88/100 and a GF Value™ of $0.96. The stock has 5 warning signs investors should review. Among 582 Healthcare Providers & Services companies, China Resources Medical Holdings Co ranks better than 64.78% on this metric.
The historical rank and industry rank for China Resources Medical Holdings Co's Return-on-Tangible-Equity or its related term are showing as below:
CMHDF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -108.38 Med: 14.75 Max: 26.45
Current: 17.84
During the past 13 years, China Resources Medical Holdings Co's highest Return-on-Tangible-Equity was 26.45%. The lowest was -108.38%. And the median was 14.75%.
CMHDF's Return-on-Tangible-Equity is ranked better than 64.78% of 582
companies
in the Healthcare Providers & Services industry
Industry Median: 9.965
vs CMHDF: 17.84
China Resources Medical Holdings Co (OTCPK:CMHDF) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
China Resources Medical Holdings Co Return-on-Tangible-Equity Related Terms
China Resources Medical Holdings Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Medical Holdings Co Return-on-Tangible-Equity Chart
CMHDF vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, China Resources Medical Holdings Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Resources Medical Holdings Co Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, China Resources Medical Holdings Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where China Resources Medical Holdings Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 10.91% mean?
China Resources Medical Holdings Co (CMHDF) has a Return-on-Tangible-Equity of 10.91% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on China Resources Medical Holdings Co and its competitors. This is 26% below median its historical median of 14.75. According to the industry distribution chart, China Resources Medical Holdings Co ranks #205 out of 582 companies in the Healthcare Providers & Services industry, placing it in the top 35.2%.
Is China Resources Medical Holdings Co's Return-on-Tangible-Equity too high?
China Resources Medical Holdings Co's current Return-on-Tangible-Equity of 10.91% is 26% below median its 10-year median of 14.75. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 9.97. China Resources Medical Holdings Co's value of 10.91% is 9.5% above this industry median. Based on the distribution chart, China Resources Medical Holdings Co ranks #205 out of 582 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, China Resources Medical Holdings Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does China Resources Medical Holdings Co's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, China Resources Medical Holdings Co ranks #205 out of 582 companies for Return-on-Tangible-Equity. This puts China Resources Medical Holdings Co in the upper half of its industry. The industry median Return-on-Tangible-Equity is 9.97. China Resources Medical Holdings Co's value of 10.91% is 9.5% above this benchmark. While the company's 10-year median is 14.75 vs. the industry median of 9.97, China Resources Medical Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 9.97, based on 582 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Resources Medical Holdings Co's current Return-on-Tangible-Equity of 10.91% is 9.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on China Resources Medical Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 9.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Resources Medical Holdings Co's current Return-on-Tangible-Equity is 10.91%, which is 26% below median its own 10-year median of 14.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Medical Holdings Co stock overvalued right now?
China Resources Medical Holdings Co (CMHDF) has a current Return-on-Tangible-Equity of 10.91%. The stock's GF Value™ is $0.96, compared to a current price of $0.58 — trading 39.6% below its estimated fair value. The current Return-on-Tangible-Equity is 10.91%, which is 26% below median its 10-year median of 14.75 and 9.5% above the Healthcare Providers & Services industry median of 9.97. China Resources Medical Holdings Co's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For China Resources Medical Holdings Co (CMHDF), the current Return-on-Tangible-Equity is 10.91% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Resources Medical Holdings Co (CMHDF) Overvalued in 2026?
Based on GuruFocus' analysis, China Resources Medical Holdings Co stock appears to be undervalued.
The current stock price of $0.58 is trading 39.6% below its estimated GF Value™ of $0.96.
Key valuation signals for CMHDF:
Return-on-Tangible-Equity: 10.91% (26% below median its 10-year median of 14.75)
GF Value™: $0.96 vs. price of $0.58 (39.6% below fair value)
Industry Position: 9.5% above the Healthcare Providers & Services median (#205 of 582)
No single metric tells the full story. See the CMHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Resources Medical Holdings Co Business Description
China Resources Medical Holdings Co Ltd is engaged in the provision of general healthcare services; provision of hospital management services, sale of pharmaceuticals, medical devices, and medical consumables, and provision of other services in the Chinese Mainland. The group has two operating segments: Hospital Business and Other Business. The Hospital Business segment includes outpatient business and inpatient business corresponding to self-owned hospitals. The Other business segment includes operation management services, supply chain services, and other ancillary services provided to participating hospitals and IOT/OT hospitals. It generates the majority of its revenue from the Hospital Business segment.
88GF Score
Get the complete analysis for CMHDF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CMHDF has been successfully added to your 
